Combination Drug Delivery via Multilamellar Vesicles Enables Targeting of Tumor Cells and Tumor Vasculature
This study demonstrates the potential of our novel targeted combination therapy delivery vehicle to improve the outcome of cancer treatment. This article is protected by copyright. All rights reserved
Source: Biotechnology and Bioengineering - Category: Biomedical Science Authors: Yarong Liu, Yu Jeong Kim, Natnaree Siriwon, Jennifer A. Rohrs, Zhiqiang Yu, Pin Wang Tags: Article Source Type: research
More News: Biomedical Science | Biotechnology | Breast Cancer | Cancer | Cancer & Oncology | Cancer Therapy | Cardiology | Cardiovascular | Heart | Melanoma | Skin Cancer | Study | Toxicology